-- Health care stocks were mixed pre-bell Friday, with the iShares Biotechnology ETF (IBB) 0.5% higher and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower.
Telix Pharmaceuticals (TLX) shares were up more than 5% after the company said the US Food and Drug Administration accepted its resubmitted new drug application for its investigational glioma imaging agent Pixclara.
Abbott Laboratories (ABT) has been ordered by a jury in Chicago to pay $53 million in compensatory damages to a group of families related to four cases over its infant formula, the Chicago Tribune reported. Shares of Abbott Laboratories were down 0.9% premarket.
Vanda Pharmaceuticals (VNDA) said it is calling on the US Food and Drug Administration to withdraw a proposal in the regulator's fiscal 2027 Congressional Budget Justification that would extend drug review timelines. Vanda Pharmaceuticals stock was up more than 1% pre-bell.